Glaxo Wellcome earmarks more for research

Pharmaceutical giant Glaxo Wellcome spent Pounds 1.15 billion on research and development in 1997, according to its annual report. The firm, which notched up global sales worth Pounds 8 billion, says it expects to spend Pounds 1.2 billion on R&D next year. It says that for the pharmaceutical industry worldwide, sales in 1997 were up 9 per cent to Pounds 166 billion.The North American market saw the greatest increase from 9 per cent growth in 1996 to 15 per cent in 1997, generating Pounds 61 billion of sales.

The United States accounts for 35 per cent of the global market. Europe has experienced a decline in growth from 9 per cent to 6 per cent. Growth in Latin America has increased from 7 per cent to 11 per cent, while in Asia Pacific growth has slowed from 13 per cent to 9 per cent.

Already registered?

Sign in now if you are already registered or a current subscriber. Or subscribe for unrestricted access to our digital editions and iPad and iPhone app.

Featured Jobs

Associate Dean (Education), Quality and Innovation AUSTRALIAN NATIONAL UNIVERSITY (ANU)

Register to continue  

You've enjoyed reading five THE articles this month. Register now to get five more, or subscribe for unrestricted access.

Most Commented

Universities to scale back liberal arts and social science courses

  • David Humphries illustration (24 September 2015)

A Russell Group tagline rap is further proof that we need to reform the academy’s approach, argues Philip Moriarty

  • World University Rankings 2015-2016 methodology

Change for the better: fuelled by more comprehensive data, the 2015-2016 rankings probe deeper than ever

  • World University Rankings

US continues to lose its grip as institutions in Europe up their game

Inspired by previous movement in 1960s, PhD students say that ‘science is not neutral’ and urge scientists to confront their assumptions